A Phase II Clinical Trial to analyse Olaparib Response in patients with BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer (COMETA-Breast study).
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Olaparib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms COMETA-Breast
- 14 Sep 2017 Status changed from not yet recruiting to recruiting.
- 11 Jan 2017 New trial record